相关实验视频

Updated: Jan 8, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

预测生物标志物:定制美学皮肤病学的新前沿

Diala Haykal, Frédéric Flament, Atchima Suwanchinda

Aesthetic surgery journal. Open forum

|December 15, 2025

概括

生物标志物和生物标志可以识别患有美观皮肤病手术并发症风险的患者. 这种方法使个性化化护理成为可能,朝着更安全,更准确和更持久的结果的预测和预防模型迈进.

科学领域:

审美皮肤病学审美皮肤病学
生物标志物和标志标志物
个性化医疗是个性化的医疗.

背景情况:

审美皮肤病学越来越多地使用先进的注射和基于能量的治疗方法.
患者的并发症,如颗粒瘤和色素过高,是由于生物变异性而产生的.
目前的决策需要更好的生物见解,以确保患者的安全.

研究的目的:

探索生物标志物和标志物在预测患者美容手术并发症风险方面的作用.
讨论人工智能在解释生物数据方面的实际应用和潜力.
倡导转向生物知情,预测和预防性的美学护理.

主要方法:

对生物标志物和标志物在美学皮肤病学中的应用进行审查和评论.
讨论现实世界的应用,包括用于分子分析的带剥离.
探索人工智能用于分析复杂的生物特征.

主要成果:

生物标志物和标志物可以识别与治疗结果相关的个体间生物变异性.
带剥离为分子患者分析提供了一种实用的方法.
人工智能有可能解释复杂的生物数据,以提供个性化的护理.

结论:

整合生物标志物和标志物可以提高美学皮肤病学中的安全性和精度.
生物知情的方法有助于过渡到预测和预防性化品护理.
基于皮肤生物学的个性化承诺更安全,更持久的审美效果.

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...